70 related articles for article (PubMed ID: 2284427)
21. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484
[No Abstract] [Full Text] [Related]
22. Effectiveness of acute nonlymphocytic leukemia induction chemotherapy in acute lymphocytic leukemia.
Cassileth PA; Bennett JM
Cancer Treat Rep; 1985 Dec; 69(12):1439-40. PubMed ID: 3865702
[TBL] [Abstract][Full Text] [Related]
23. Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
Winton EF; Miller D; Vogler WR
Cancer Treat Rep; 1981; 65(5-6):389-92. PubMed ID: 6165470
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy for acute monoblastic leukaemia.
Warne I
Nurs Times; 1994 Apr 27-May 3; 90(17):43-5. PubMed ID: 8177793
[TBL] [Abstract][Full Text] [Related]
25. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
Rokicka-Milewska R; Derulska D; Lewicki Z
Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657
[No Abstract] [Full Text] [Related]
26. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
27. Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up.
Oblon DJ; Weiner RS; Kramer BS; Ross W; Noyes WD; Boyett J; Kitchens CS
Cancer Treat Rep; 1985 Dec; 69(12):1425-7. PubMed ID: 2416439
[TBL] [Abstract][Full Text] [Related]
28. [Comparative analysis of 3 therapeutic regimens based on the combination of an anthracycline and cytosine arabinoside for remission induction in myeloblastic leukemia].
Sanz MA; Lorenzo JI; Sanz GF; Martín Aragonés G; Rafecas FJ; Martínez JA; Gomis F
Sangre (Barc); 1988 Dec; 33(6):497-504. PubMed ID: 3247626
[No Abstract] [Full Text] [Related]
29. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
[TBL] [Abstract][Full Text] [Related]
30. Multifocal reversible epithelial dysplasia mimicking carcinoma in situ after conditioning therapy with busulfan and cyclophosphamide.
Obermann E; Meidenbauer N; Zeltner R; Andreesen R; Reichle A
Bone Marrow Transplant; 1999 Aug; 24(4):446-7. PubMed ID: 10467342
[No Abstract] [Full Text] [Related]
31. Aclacinomycin, cytosine arabinoside and thioguanine in relapsed or resistant acute myeloid leukemia.
Neri A; Comis M; Brugiatelli M; Martino B; Ronco F
Haematologica; 1989; 74(1):113-4. PubMed ID: 2498174
[No Abstract] [Full Text] [Related]
32. Bortezomib-Based Regimens and Plasma Cell Leukemia.
Bolaman AZ
Turk J Haematol; 2021 Feb; 38(1):96-96. PubMed ID: 33463973
[No Abstract] [Full Text] [Related]
33. Fludarabine and plasma cell leukemia.
Björkholm M; Osby E
Eur J Haematol; 1995 May; 54(5):334-5. PubMed ID: 7781758
[No Abstract] [Full Text] [Related]
34. Long term complete remission in primary plasma cell leukemia.
Tsuyuoka R; Takahashi T; Sasaki Y; Nakamura K; Fukumoto M; Kurisu Y; Tsubakimori K; Shioi K; Nakao K
Intern Med; 1995 Apr; 34(4):251-4. PubMed ID: 7606092
[TBL] [Abstract][Full Text] [Related]
35. Plasma cell leukemia: an evaluation of response to therapy.
Noel P; Kyle RA
Am J Med; 1987 Dec; 83(6):1062-8. PubMed ID: 3503574
[TBL] [Abstract][Full Text] [Related]
36. Oral Tumor Revealing Primary Plasma-cell Leukemia.
Ahnach M; Youssefi H; Bendari M
Balkan Med J; 2021 Nov; 38(6):392-393. PubMed ID: 34860167
[No Abstract] [Full Text] [Related]
37. [Diagnosis and treatment of plasma cell leukemia].
Fülle HH; Pribilla W
Dtsch Med Wochenschr; 1973 Apr; 98(17):874-81. PubMed ID: 4571885
[No Abstract] [Full Text] [Related]
38. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
Nandakumar B; Kumar SK; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Go RS; Jevremovic D; Kyle RA; Gertz MA; Rajkumar SV; Gonsalves WI
Mayo Clin Proc; 2021 Mar; 96(3):677-687. PubMed ID: 33673918
[TBL] [Abstract][Full Text] [Related]
39. Abrupt Development of Plasma Cell Leukemia in a Patient with Chronic Anemia under Follow-up.
Farzaneh MR; Moradi A; Ravanbod MR; Daghbashi M
Arch Iran Med; 2016 Jan; 19(1):75-7. PubMed ID: 26702753
[TBL] [Abstract][Full Text] [Related]
40. [Plasmacytic leukemia: report of 13 cases].
Kraj M; Maj S; Rostkowska J; Letowska M
Nowotwory; 1982; 32(3):175-86. PubMed ID: 7155913
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
